Koers Argos Therapeutics Inc Nasdaq
Aandelen
US0402212023
Farmaceutische producten
Omzet 2016 | 945K 872K | Omzet 2017 | 1,9 mln. 1,75 mln. | Marktkapitalisatie | 13,18 mln. 12,15 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2016 | -53 mln. -48,87 mln. | Nettowinst (verlies) 2017 | -40 mln. -36,88 mln. | EV/omzet 2016 | 200 x |
Nettoliquiditeiten 2016 | 13,11 mln. 12,09 mln. | Nettoschuld 2017 | 4,27 mln. 3,93 mln. | EV/omzet 2017 | 9,19 x |
K/w-verhouding 2016 |
-2,96
x | K/w-verhouding 2017 |
-0,22
x | Werknemers | - |
Dividendrendement 2016 * |
-
| Dividendrendement 2017 |
-
| Vrij verhandelbaar | 88,73% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,00% | 90,02 mld. | |
-1,18% | 39,15 mld. | |
-15,83% | 31,71 mld. | |
+62,86% | 26,47 mld. | |
-21,68% | 14,34 mld. | |
-8,73% | 12,89 mld. | |
-15,05% | 11,18 mld. | |
-45,69% | 10,97 mld. | |
+4,94% | 8,94 mld. |